Senior insider sale
Chief Commercial Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$8.1K
10.26K shares
What this filing means
BALDRY MARK plans to sell 10.26K shares of X4 PHARMACEUTICALS, INC valued at approximately $8.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/1/2023ACC: 0001973141-23-000265
Officer· Chief Commercial Officer
Since Nov 2022
10.26K
Shares to sell
$8.1K
Approx. market value
10.26K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
NA
11/1/2023
10.26KTotal acquired10.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/1/2023 | RSU NA | 10.26K | — |
| Total | 10.26K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
10.26K
Market value
$8.1K
11/1/2023
Total
Units
10.26K
Value
$8.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/1/2023 | 10.26K | $8.1K | Nasdaq | Planned |
| Total | 10.26K | $8.1K | ||